depression and insomnia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) aged >= 18 years, male and female; 2) meet the diagnostic criteria of DSM-5 fordepression, the current 14 = 10; 4) may be accompanied by anxiety symptoms, but currently does not meet any anxiety disorders diagnostic criteria,14 <= HAMA <= 29; 5) have sufficient education and understanding to complete this study to be examined and evaluated; 6) voluntary participation in this clinical trial and signature of informed consent.
Exclusion criteria
Exclusion criteria: 1) DSM-5 other sleep problems, such as apnea syndrome, restless leg syndrome; 2) exclude women who are pregnant, nursing or planning to become pregnant during the study; 3) insomnia caused by alcohol or substance abuse; 4) severe cognitive problems; 5) obvious negative risk, HAMD-17 article 2 score >= 3; 6) patients who have been or are currently diagnosed with bipolar and related disorders, coercion and related disorders, schizophrenia spectrum and other psychiatric disorders, trauma and stress-related disorders, separation disorders, eating disorders; 7) exclude patients with history of epilepsy or other serious somatic diseases; 8) exclude persons receiving MECT treatment for nearly one month; 9) excluding those who have received systemic psychotherapy for more than 3 months in a row; 10) the researchers believe that it is not suitable to participate in this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SE;decrease of depressive symptoms; | — |
Countries
China
Contacts
Shanghai Mental Health Center